Selected article for: "etanercept second line treatment and second line"
Author: De Jong, Cornelis N.; Saes, Lotte; Klerk, Clara P. W.; Van der Klift, Marjolein; Cornelissen, Jan J.; Broers, Annoek E. C.
Title: Etanercept for steroid-refractory acute graft-versus-host disease: A single center experience
  • Document date: 2017_10_26
    • ID: 1hcp36cw_16
    Snippet: The primary endpoint of the study was the best overall response rate (CR and PR) after start of second-line treatment with etanercept. Secondary endpoints were OS and toxicity. OS was calculated using the actuarial method of Kaplan and Meier from the time of starting second-line treatment with etanercept until death. Causes of death were classified as treatment-related mortality (TRM) or relapse-related mortality......
    Document: The primary endpoint of the study was the best overall response rate (CR and PR) after start of second-line treatment with etanercept. Secondary endpoints were OS and toxicity. OS was calculated using the actuarial method of Kaplan and Meier from the time of starting second-line treatment with etanercept until death. Causes of death were classified as treatment-related mortality (TRM) or relapse-related mortality.

    Search related documents:
    Co phrase search for related documents
    • death cause and overall response rate: 1, 2, 3
    • death cause and primary endpoint: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • death cause and response rate: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • death cause and second line: 1, 2, 3, 4, 5
    • death cause and secondary endpoint: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • death cause and study primary endpoint: 1, 2, 3
    • death cause and toxicity os: 1
    • overall response rate and PR CR overall response rate: 1, 2
    • overall response rate and primary endpoint: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
    • overall response rate and response rate: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • overall response rate and second line: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • overall response rate and second line treatment: 1, 2, 3, 4, 5, 6, 7, 8
    • overall response rate and secondary endpoint: 1, 2, 3, 4, 5, 6
    • overall response rate and study primary endpoint: 1, 2
    • PR CR overall response rate and primary endpoint: 1
    • PR CR overall response rate and response rate: 1, 2
    • PR CR overall response rate and second line: 1
    • PR CR overall response rate and second line treatment: 1
    • primary endpoint and response rate: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25